Latest #Phase 2 News
Travel Vaccine maker Valneva cuts forecast after revenue drops 40%
Valneva cut its 2026 outlook after revenue slid 40%, while travel vaccine sales held ...
#Phase 2
1
Posts
Valneva cut its 2026 outlook after revenue slid 40%, while travel vaccine sales held ...